TAILIEUCHUNG - Gastric Carcinoma- New Insights into Current Management

Gastric cancer is the second most common cause of cancer-related death in the world. There are no screening tests available for its diagnosis, therefore patients usually presents in late stages, associated with poor prognosis. Currently, many efforts are made toward new advances in the treatment strategies. The book makes an insight into the assessment of premalignant lesions, current management of early gastric cancer, risk and protective factors in gastric carcinogenesis. | GASTRIC CARCINOMA-NEW INSIGHTS INTO CURRENT MANAGEMENT Edited by Daniela Lazar Gastric Carcinoma- New Insights into Current Management http 45896 Edited by Daniela Lazăr Contributors Ekambaram Ganapathy Devaraja Rajasekaran Asokan Devarajan Muhammad Farooq Shukkur Muhammed Farooq Abdul Shukkur Sakthisekaran Dhanapal Murugan Sivalingam Eriko Maeda Kuo-Wang Tsai Chung-Man Leung Hung-Wei Pan Takehiro Okabayashi Yasuo Shima Okan Akturk Jolanta Czyzewska Daniela Lazar Elvira Garza Gonzalez Guillermo Perez Perez Shinya Shimada Masafumi Kuramoto Jae Y. Ro Sun - Mi Lee Kyoung-Mee Kim Published by InTech Janeza Trdine 9 51000 Rijeka Croatia Copyright 2013 InTech All chapters are Open Access distributed under the Creative Commons Attribution license which allows users to download copy and build upon published articles even for commercial purposes as long as the author and publisher are properly credited which ensures maximum dissemination and a wider impact of our publications. After this work has been published by InTech authors have the right to republish it in whole or part in any publication of which they are the author and to make other personal use of the work. Any republication referencing or personal use of the work must explicitly identify the original source. Notice Statements and opinions expressed in the chapters are these of the individual contributors and not necessarily those of the editors or publisher. No responsibility is accepted for the accuracy of information contained in the published chapters. The publisher assumes no responsibility for any damage or injury to persons or property arising out of the use of any materials instructions methods or ideas contained in the book. Publishing Process Manager Danijela Duric Technical Editor InTech DTP team Cover InTech Design team First published February 2013 Printed in Croatia A free online edition of this book is available at Additional hard copies can be obtained from

• Y học thường thức
• morphologic classification
• molecular changes
• Gastric Carcinoma
• Pancreas Carcinoma
• Colorectal Carcinoma
• Bladder Carcinoma
• Urinary bladder carcinoma
• Muscularis propris invasion
• Urinary bladder carcinoma cases
• Muscularis propria invasion
• Detection of Muscularis propria invasion
• BMC Cancer
• Urothelial carcinoma of the urinary bladder
• Bladder cancer
• Relative survival
• Registry data
• Urinary bladder neoplasms
• Lymph nodes
• Age at diagnosis
• Muscle invasive bladder urothelial carcinoma
• Multivariate analyses
• Transitional cell carcinoma
• Human cancers
• Canine bladder cancer
• Cell lines
• Urothelial carcinoma of the bladder
• Yes associated protein 1
• Multiple tumors
• Squamous cell carcinoma
• Immune checkpoint inhibitors
• Bladder cancer therapy
• Pure squamous cell carcinoma
• Cancer types
• Pathological features
• Liver Carcinoma
• Extrahepatic Bile
• Non muscle invasive bladder cancer
• Urine based assay
• DNA biomarkers
• Carcinoma in situ
• Muscle invasive bladder cancer
• RNAseq expression patterns
• Invasive urothelial carcinoma
• Pathologic presentation
• Molecular subtypes
• Human bladder tumors
• Squamous cell carcinoma of the bladder
• Survival analysis
• Significant clinical parameters
• Establish nomograms
• Bladder urothelial carcinoma
• Heterogeneous behavior
• RNA sequencing
• Cell proliferation
• COX regression analysis
• Renal cell carcinoma
• Distinguish cancers
• Healthy controls
• Altered metabolomic pathways
• Small cell carcinoma of the bladder
• Contrast enhanced ultrasound
• Conventional ultrasound
• Time intensity curves
• Squamous differentiation
• Urothelial carcinoma
• Transurethral resection
• Bladder tumor
• Radical cystectomy
• Ecological factors
• N acetyltransferase 2
• Urothelial bladder carcinoma
• Nuclear localization signals
• Prognostic marker
• AT motif binding factor 1
• Metabolic syndrome
• Emerging condition worldwide
• Odds ratios
• Upper tract urothelial carcinoma
• Radical cystectomy
• Radical nephroureterectomy
• Upper urinary tract
• Post translational modifications
• Stress granules
• ERH gene
• MYC gene
• Underlying mechanism
• Human bladder urothelial carcinoma
• Head and neck carcinoma
• Long non coding RNA
• Cancer in Egypt
• Schistosomiasis and Cancer in Egypt
• Bladder cancer in Egypt
• Urothelial cancer
• Locally advanced
• Checkpoint inhibitor